Section: Bilateral Contracts and Grants with Industry

PGXIS

Participant : Christophe Biernacki.

PGXIS is a UK pharmacogenomics company aiming to discover virtual drugs. Its business model relies on its star technology, named Taxonomy3, a ground breaking mathematical method. Applied to Big Genetic Data, it delivers novel drug targets that are biologically confirmed. These drug targets will drive its drug discovery programmes. This six months contract aims at developping mathematical tool for accelerating convergence rate of Taxonomy3. From a scientific point of view, it corresponds to define specific importance sampling methods related to the Monte Carlo process involved in Taxonomy3.